Immunology and Microbiology
Human Immunodeficiency Virus
100%
Hepatitis C Virus
67%
Human Immunodeficiency Virus 1
49%
Coinfection
35%
Hepatitis C
34%
Blood Plasma
32%
Hepatitis B Virus
28%
interferon
22%
T-Helper Cell
22%
CD4
20%
Macrophage
20%
C-Reactive Protein
20%
Monocyte
18%
Viral Replication
15%
T Cell Activation
14%
T Cell
13%
Hepatitis Virus
12%
CD14
10%
Lymph Node
10%
CD4 Lymphocyte Count
8%
Real-Time Polymerase Chain Reaction
7%
Francisella
7%
Gamma Interferon Inducible Protein 10
7%
Surfactant Protein A
6%
Interleukin 18
6%
Francisella novicida
6%
Francisella Tularensis
6%
Interferon-Stimulated Gene
6%
Droplet Digital Polymerase Chain Reaction
6%
Liver Transplantation
6%
Hepatitis B
6%
Immunocompetent Cell
6%
Immune Reconstitution
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Tumor Necrosis Factor
5%
Transplant Procedure
5%
Simian Immunodeficiency Virus
5%
Body Mass
5%
Blood Level
5%
Rigidity
5%
Somatomedin C
5%
Cycle Threshold
5%
Limulus
5%
Cell Lysate
5%
Induced Pluripotent Stem Cell
5%
DNA Virus
5%
Virus Reactivation
5%
Metagenomic Next-Generation Sequencing
5%
COVID-19
5%
Gene Loss
5%
Keyphrases
Hepatitis C Virus
53%
Antiretroviral Therapy
37%
Hepatocytes
28%
Human Immunodeficiency Virus Type 1 (HIV-1)
28%
AIDS/HIV
26%
Hepatitis B Virus
22%
Hepatitis C
20%
Immune Activation
18%
Soluble CD14 (sCD14)
18%
HIV Reservoir
16%
Interferon-α (IFN-α)
14%
Infected Cells
13%
HIV Co-infection
12%
Liver
12%
People Living with HIV (PLHIV)
12%
CD4+ T
12%
T Cells
11%
Lipopolysaccharide
11%
HIV Patients
11%
Disease Progression
11%
Hepatitis B Virus DNA
10%
Direct-acting Antivirals
10%
Interleukin-18 (IL-18)
10%
Combined Antiretroviral Therapy (cART)
10%
Monocyte Activation
10%
Viral Kinetics
10%
Direct-acting Antiviral Therapy
10%
Type I Interferon
10%
Hepatitis B Surface Antigen (HBsAg)
10%
Lymph Node
10%
Hepatitis C Virus Infection
10%
Confidence Interval
9%
Liver Disease
8%
Virus
7%
Pregenomic RNA (pgRNA)
7%
Antiretroviral Therapy Initiation
7%
Hepatitis B Virus Replication
7%
Virologic Suppression
7%
HIV-1 Infection
7%
Co-infection
7%
Immune Markers
7%
Hepatitis C Treatment
7%
Human Immunodeficiency Virus Infection
6%
Clinical Failure
6%
Microbial Translocation
6%
Viral Dynamics
6%
People Who Inject Drugs
6%
Cirrhosis
6%
C-reactive Protein
6%
Liver Disease Progression
6%
Medicine and Dentistry
Human Immunodeficiency Virus
55%
Hepatitis B Virus
34%
Hepatocyte
32%
Antiretroviral Therapy
22%
Hepatitis C Virus
16%
T Cell
11%
T-Helper Cell
10%
Virus DNA
10%
Interferon
10%
Mixed Infection
10%
Virus RNA
9%
Infection
8%
Lipopolysaccharide
8%
Virus Replication
8%
Laser Capture Microdissection
6%
Circular DNA
6%
Hepatitis B
6%
Droplet Digital Polymerase Chain Reaction
6%
T Cell Activation
6%
C Reactive Protein
6%
Macrophage
5%
Mycobacterial Infection
5%
Antiviral Therapy
5%
Hepatitis C
5%
Autotaxin
5%
Fibrosis
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Gene Loss
5%
Portosystemic Anastomosis
5%
Liver Cirrhosis
5%
Liver Graft
5%
Endotoxin
5%
Silo-Filler's Disease
5%
Cholinesterase
5%
Tumor Necrosis Factor
5%
Hepatitis B(e) Antigen
5%
Cohort Analysis
5%
Genomic RNA
5%
Membrane Antigen
5%
4 Iodo 2,5 Dimethoxyamphetamine
5%
Immunocompetent Cell
5%
Men Who Have Sex with Men
5%
Cross Sectional Study
5%
